Literature DB >> 19668771

Optic nerve sheath meningocele.

Juan Carlos Mesa-Gutiérrez1, Silvia Muñoz Quiñones, Jorge Arruga Ginebreda.   

Abstract

A 53-year-old man presented with a 5-month history of visual loss in his left eye. Visual acuity could be corrected to 20/20 with an increased hyperopic correction. Dilated funduscopy showed faint choroidal folds and elevation of the left optic disc. The coronal view of T2-weighted magnetic resonance imaging demonstrated a fluid-filled dilated sheath surrounding normal optic nerves. General physical examination and cerebrospinal fluid analysis were normal. The subject was diagnosed as having dural ectasia of the optic nerve sheath and followed a course of acetazolamide 250 mg twice daily for three months, and displayed good anatomical and functional results during a 2-year follow-up period. Despite the fact that several authors have recommended an optic nerve decompression, most of the patients follow a benign clinical course. The role of corticosteroids is not described in the literature. Raised levels of proteins in the cerebrospinal fluid in the perioptic subarachnoidal space could be a determining factor. On the basis of an osmotic gradient between the cerebral subarachnoid space and perioptic subarachnoid space, carbonic anhydrase inhibitors could be beneficial. In contrast to other reports, we believe that surgical intervention could be reserved for patients with rapid or progressive optic nerve dysfunction.

Entities:  

Keywords:  optic nerve; optic nerve meningocoele; optic nerve tumors; perineural subaracnoid space

Year:  2008        PMID: 19668771      PMCID: PMC2694015          DOI: 10.2147/opth.s2689

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

Meningocele is a primary cerebrospinal fluid (CSF) cyst of the optic nerve sheath. Presenting symptoms are often related to involvement of the optic nerve, with a slow or rapid decrease in visual acuity. Computerized tomography (CT) and magnetic resonance imaging (MRI) revealed a tubular-cystic enlargement of the optic nerve/optic-sheath complex with thickening of the optic nerve. Radiological differential diagnosis should include optic nerve tumors such as gliomas, meningiomas, and arachnoid cysts involving the optic nerve sheath. Early surgical management by means of optic nerve/optic nerve sheath decompression affords an improvement of visual function. We report a patient with optic nerve sheath meningocele treated with acetazolamide who showed a maintained improvement during a 2-year follow-up period.

Case report

We report the case of a 53-year-old man who presented with a 5-month history of distorted vision in his left eye. The best corrected visual acuity was 20/40 in the left eye and could be corrected to 20/20 with +2.00D. He was able to perceive all Ishihara color plates and no afferent pupillary defect was present. Humphrey’s visual field analysis revealed an enlarged blind spot. Dilated funduscopy showed an elevation of the left optic disc and choroidal folds above the nerve extending into the macula (Figure 1).
Figure 1

Elevation of the left optic disc and choroidal folds.

A MRI scan with fat-suppression and an off-axis coronal view was performed. On coronal images, a dilated optic nerve sheath was identified as containing a CSF-intensity lesion that was hyperintense on T2-weighted images (Figure 2).
Figure 2

Hyperintense cerebrospinal fluid-intensity lesion.

The optic nerves were normal, and there was no evidence of tumor in the brain or orbit. A lumbar puncture was performed. CSF opening pressure was 22 mmHg and chemical analysis of CSF was normal. The subject was, therefore, diagnosed as having dural ectasia of the optic nerve sheath, which is also known as optic nerve meningocoele, with intracranial hypertension. Once the diagnosis had been confirmed and the neurosurgical team consulted, the decision to treat with acetazolamide 250 mg twice daily was made. The left optic disc returned to normal within three weeks (Figure 3), and Humphrey’s visual field analysis showed no anomalies. The patient was maintained on acetazolamide for three months and remained stable over the next 24 months. In all follow-up examinations, nerve function was normal with a BCVA of 20/20 without optic correction at 24 months.
Figure 3

Normal left optic disc.

Discussion

The term “optic nerve sheath meningocele” was first coined in Garrity and colleague’s landmark paper in which 13 patients were described with this condition (Garrity et al 1990). As such, the condition arises from the perineural subarachnoid space of the optic nerve, and should be differentiated from the congenital accumulation of CSF in the perioptic subarachnoid space. In such cases, the lesion is developmental, resulting from an abnormal CSF flow through a diverticulum within the arachnoid membrane. Moreover, a dilation of the optic nerve/optic nerve sheath complex could be secondary to a neoplastic apical mass such as meningioma, vascular hamartoma, glioma, neurofibromatosis, von Hippel-Lindau disease, hemagioendoelioma, or cranio-orbital fracture. The origin of the optic nerve sheath meningocele is still unknown. Hayreh (1984) pointed out that the perioptic subarachnoid space is narrowest in the region of the optic canal, so that the bony part of the optic canal and the cranio-orbital junction could be considered contributing factors in the dynamic alterations of CSF in the perioptic subarachnoid space. Therefore, congenital narrowing of the optic or congenital cranio-orbital junction anomalies could cause optic nerve meningocele. There were no pathognomonic symptoms that may lead one to suspect an optic nerve dural ectasia. Garrity and colleagues (1990) reported visual blurring and headache as two main symptoms, along with proptosis and optic disc shunt vessels as rare presenting features. Apart from its relation to neurofibromatosis type 1 (Lovblad et al 1994; Doi et al 1997), dural ectasia of the optic nerve sheath has been associated with acquired hypermetropia and choroidal folds (Dailey et al 1986; Garrity et al 1990). The diagnosis can be confirmed by MRI with high spatial resolution, fat-suppression with contrast techniques in off-axis sagittal views. In coronal MRI, it is possible to see both the optic nerve and sheath: optic nerve sheath meningocele appears as a moderately dilated sheath with fluid and a normal or thickened optic nerve (“bull’s eye”). Short TE/short TR spin echo sequences or chemical shift imaging give the best results. MRI allows a more detailed differential diagnosis of optic nerve meningocele, including optic nerve tumors such as gliomas or meningiomass, especially in the cystic subtype of these tumors. The role of corticosteroids is not described in the literature; however, in view of its presumed pathology, it may not be beneficial. Surgical intervention involving optic nerve sheath fenestration could be reserved for patients with progressive optic nerve dysfunction. In summary, optic nerve dural ectasia is a saccular dilatation of the optic nerve sheath. It can be suspected based on the evidence of visual blurring or retrobulbar pressure. Ocular examination may show signs of optic nerve dysfunction. Choroidal folds and hypermetropic shift are suggestive of a meningocoele. The radiological investigation of choice is MRI with techniques to emphasize high spatial resolution and optic nerve anatomy. Surgical intervention is reserved for severe cases.
  5 in total

1.  Dural ectasia of the optic nerve sheath in neurofibromatosis type 1: MRI manifestations.

Authors:  J Doi; A Uchino; A Kato; T Koga; S Kudo
Journal:  Radiat Med       Date:  1997 May-Jun

Review 2.  Optic nerve sheath meningoceles. Clinical and radiographic features in 13 cases with a review of the literature.

Authors:  J A Garrity; J C Trautmann; G B Bartley; G Forbes; J D Bullock; T W Jones; R R Waller
Journal:  Ophthalmology       Date:  1990-11       Impact factor: 12.079

3.  The natural history and CT appearance of acquired hyperopia with choroidal folds.

Authors:  R A Dailey; R P Mills; G K Stimac; W T Shults; R E Kalina
Journal:  Ophthalmology       Date:  1986-10       Impact factor: 12.079

4.  The sheath of the optic nerve.

Authors:  S S Hayreh
Journal:  Ophthalmologica       Date:  1984       Impact factor: 3.250

5.  Dural ectasia of the optic nerve sheath in neurofibromatosis type 1: CT and MR features.

Authors:  K O Lövblad; L Remonda; C Ozdoba; P Huber; G Schroth
Journal:  J Comput Assist Tomogr       Date:  1994 Sep-Oct       Impact factor: 1.826

  5 in total
  7 in total

1.  Optic Nerve Sheath Meningocele: A Case Report.

Authors:  E Halimi; O Wavreille; R Rosenberg; I Bouacha; J-P Lejeune; S Defoort-Dhellemmes
Journal:  Neuroophthalmology       Date:  2013-03-22

2.  Dural ectasia of the optic nerve sheath: is it always benign?

Authors:  Berker Bakbak; Hava Dönmez; Tülay Kansu; Hayyam Kiratli
Journal:  Eye Brain       Date:  2009-11-19

3.  The relation of optic nerve sheath diameter (ONSD) and intracranial pressure (ICP) in pediatric neurosurgery practice - Part II: Influence of wakefulness, method of ICP measurement, intra-individual ONSD-ICP correlation and changes after therapy.

Authors:  Susanne R Kerscher; Daniel Schöni; Felix Neunhoeffer; Markus Wolff; Karin Haas-Lude; Andrea Bevot; Martin U Schuhmann
Journal:  Childs Nerv Syst       Date:  2019-08-08       Impact factor: 1.475

4.  Dural ectasia of the optic nerve sheath.

Authors:  Hanane Hadj Kacem; Lehcen Hammani; Ali Ajana; Itimad Nassar
Journal:  Pan Afr Med J       Date:  2014-02-27

5.  Optic nerve sheath meningocele.

Authors:  Musleh Algarni; Pejman J Maralani; Arun Ne Sundaram
Journal:  Int Med Case Rep J       Date:  2018-09-10

Review 6.  The Effects of Space Radiation and Microgravity on Ocular Structures

Authors:  Bahadır Özelbaykal; Gökhan Öğretmenoğlu; Şansal Gedik
Journal:  Turk J Ophthalmol       Date:  2022-02-23

7.  Arachnoid cyst in oculomotor cistern.

Authors:  Min-Kyun Kim; Hyun Seok Choi; Sin-Soo Jeun; So-Lyung Jung; Kook-Jin Ahn; Bum-soo Kim
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.